| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,695 |
21,786 |
$596K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,171 |
6,576 |
$227K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,335 |
2,315 |
$206K |
| S8301 |
Infection control supplies, not otherwise specified |
20,405 |
17,047 |
$195K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,227 |
2,201 |
$184K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,559 |
4,332 |
$171K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,942 |
1,928 |
$155K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
11,597 |
6,014 |
$124K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,070 |
1,057 |
$83K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,575 |
3,536 |
$69K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,885 |
4,681 |
$42K |
| 87428 |
|
571 |
557 |
$41K |
| 99429 |
|
647 |
644 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,007 |
1,465 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,693 |
2,480 |
$11K |
| 90461 |
|
2,831 |
2,137 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
158 |
148 |
$8K |
| 99000 |
|
1,048 |
1,011 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
80 |
80 |
$7K |
| 0071A |
|
140 |
140 |
$5K |
| 96161 |
|
2,575 |
2,552 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
441 |
439 |
$5K |
| 0072A |
|
113 |
113 |
$5K |
| 0001A |
|
120 |
120 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
118 |
111 |
$4K |
| 0002A |
|
112 |
112 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
254 |
252 |
$4K |
| 87807 |
|
416 |
390 |
$3K |
| 83655 |
|
238 |
238 |
$2K |
| 99051 |
|
141 |
135 |
$558.76 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
14 |
$554.04 |
| 0011A |
|
14 |
14 |
$488.00 |
| 0012A |
|
13 |
12 |
$448.00 |
| 90671 |
|
337 |
336 |
$432.34 |
| 0081A |
|
12 |
12 |
$400.00 |
| 81003 |
|
131 |
119 |
$147.42 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$92.08 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
6,586 |
6,277 |
$40.59 |
| 97802 |
|
6,088 |
6,022 |
$8.66 |
| 90686 |
|
2,976 |
2,943 |
$1.33 |
| 90651 |
|
267 |
264 |
$0.13 |
| 90621 |
|
259 |
256 |
$0.09 |
| 90619 |
|
91 |
90 |
$0.03 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
3,168 |
3,136 |
$0.00 |
| 90698 |
|
668 |
665 |
$0.00 |
| 91307 |
|
280 |
257 |
$0.00 |
| 90680 |
|
274 |
272 |
$0.00 |
| 90744 |
|
174 |
174 |
$0.00 |
| 91301 |
|
31 |
31 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |
| 96127 |
|
56 |
56 |
$0.00 |
| 90710 |
|
136 |
136 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,574 |
2,543 |
$0.00 |
| 90670 |
|
581 |
578 |
$0.00 |
| 90734 |
|
197 |
197 |
$0.00 |
| 90633 |
|
240 |
239 |
$0.00 |
| 90715 |
|
15 |
15 |
$0.00 |
| 91300 |
|
266 |
234 |
$0.00 |
| 91320 |
|
13 |
13 |
$0.00 |
| 91308 |
|
19 |
17 |
$0.00 |